Real-world effectiveness of onabotulinumtoxinA treatment for the prevention of headaches in adults with chronic migraine in Australia: a retrospective study

BACKGROUND: OnabotulinumtoxinA (BOTOX®, Allergan plc, Dublin, Ireland) is approved for the preventive treatment of headaches in adult patients with chronic migraine (CM) in Australia by the country’s reimbursement mechanism for medicines, the Pharmaceutical Benefits Scheme (PBS). To our knowledge, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Stark, Catherine, Stark, Richard, Limberg, Nicole, Rodrigues, Julian, Cordato, Dennis, Schwartz, Raymond, Jukic, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734349/
https://www.ncbi.nlm.nih.gov/pubmed/31307383
http://dx.doi.org/10.1186/s10194-019-1030-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734349/
https://www.ncbi.nlm.nih.gov/pubmed/31307383
http://dx.doi.org/10.1186/s10194-019-1030-z

Ejemplares similares